Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0119614
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize With PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

DNA Methyltransferase Expression in Triple-Negative Breast Cancer Predicts Sensitivity to Decitabine

Journal of Clinical Investigation
Medicine
2018English

Expression of DNA Damage Response Proteins in Gastric Cancer: Comprehensive Protein Profiling and Histological Analysis

International Journal of Oncology
Cancer ResearchOncology
2018English

Inhibition of mTOR Downregulates Expression of DNA Repair Proteins and Is Highly Efficient Against BRCA2-mutated Breast Cancer in Combination to PARP Inhibition

Oncotarget
Oncology
2018English

Muc1-C Integrates Chromatin Remodeling and Parp1 Activity in the Dna Damage Response of Triple-Negative Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2019English

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

Selinexor Reduces the Expression of DNA Damage Repair Proteins and Sensitizes Cancer Cells to DNA Damaging Agents

Oncotarget
Oncology
2018English

Expression of Genes Involved in DNA Repair and Cell Cycle Checkpoint Pathways in Triple Negative Compared to Luminal a Breast Cancer: A Molecular Characterization

Hereditary Cancer in Clinical Practice
OncologyGenetics
2012English

Checkpoint Inhibitors in Triple-Negative Breast Cancer (TNBC): Where to Go From Here

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy